Siemers Eric 4
4 · Acumen Pharmaceuticals, Inc. · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Siemers Eric
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-01-18$3.71/sh−3,124$11,604→ 117,576 total
Footnotes (2)
- [F1]Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2023.
- [F2]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.7103 and $3.7150. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.